S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
3 Steel Stocks Could Soar on New China Tariffs
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
3 Steel Stocks Could Soar on New China Tariffs
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
3 Steel Stocks Could Soar on New China Tariffs
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
3 Steel Stocks Could Soar on New China Tariffs
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies

Inhibrx (INBX) SEC Filings & 10K Form

$34.45
-0.16 (-0.46%)
(As of 04/18/2024 ET)

Recent Inhibrx SEC Filings

DateFilerForm TypeView
03/28/2024
3:36 PM
Deck Kelly (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
3:22 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/22/2024
3:54 PM
Deck Kelly (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
2:56 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/21/2024
3:36 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
3:50 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
3:46 PM
Deck Kelly (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
3:48 PM
Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:22 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2024
10:34 AM
Eckelman Brendan P. (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2024
5:04 PM
Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
3:20 PM
Deck Kelly (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
2:28 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
3:41 PM
Deck Kelly (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
1:58 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
5:26 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:26 PM
Inhibrx (Filer)
Form PREM14A
02/28/2024
8:10 AM
Inhibrx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2024
8:12 AM
Inhibrx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2024
3:30 PM
Inhibrx (Filer)
Form DEFA14A
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Inhibrx (Subject)
Form SC 13G/A
01/23/2024
4:25 PM
Inhibrx (Filer)
Form DEFA14A
01/23/2024
9:10 AM
Inhibrx (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/23/2024
5:35 AM
Inhibrx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
5:38 AM
Inhibrx (Filer)
Form DEFA14A
11/02/2023
8:16 AM
Inhibrx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2023
7:44 PM
HALVORSEN OLE ANDREAS (Reporting)
Inhibrx (Issuer)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Parent GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2023
8:03 AM
Inhibrx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2023
8:03 AM
Inhibrx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2023
8:01 AM
Inhibrx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:INBX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners